CHARACTERISTICS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS.

被引：1
|
作者：
Ghandorah, Salim [1 ]
Yilmaz, Serdar [1 ]
Abadi, Abdulnaser [1 ]
Rahmanian, Taleb [2 ]
Wang, Jinguo [2 ]
Khan, Faisal M. [1 ,2 ]
Berka, Noureddine [1 ,2 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Calgary Lab Serv, Calgary, AB, Canada
来源：
HUMAN IMMUNOLOGY | 2015年 / 76卷
关键词：
D O I：
10.1016/j.humimm.2015.07.224
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P174
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [21] IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients
    Hamdani, Gilad
    Goebel, Jens W.
    Brailey, Paul
    Portwood, Elizabeth A.
    Hooper, David K.
    Girnita, Alin L.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (05)
  • [22] Liver Transplant Recipients Successfully Weaned Off Immunosuppression Lack Donor-Specific Anti-HLA Antibodies.
    Castellaneta, Antonino
    Mazariegos, George V.
    Girnita, Alin
    Bentlejewski, Carol
    Ku, Natalie
    Thomson, Angus W.
    Zeevi, Adriana
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 481 - 481
  • [23] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
  • [24] Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies.
    Louis, K.
    Viglietti, D.
    Pievani, D.
    Aubert, O.
    Glotz, D.
    Legendre, C.
    Zeevi, A.
    Loupy, A.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 449 - 450
  • [25] ROLE OF RITUXIMAB FOR ISOLATED DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
    Schafer, Antonia
    Hadaya, Karine
    Villard, Jean
    Ferrari-Lacrai, Sylvie
    HLA, 2020, 95 (04) : 322 - 322
  • [26] Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy
    Martin, L
    Guignier, F
    Mousson, C
    Rageot, D
    Justrabo, E
    Rifle, G
    TRANSPLANTATION, 2003, 76 (02) : 395 - 400
  • [27] Effects of Donor-Specific HLA Antibodies and Non-HLA Antibodies on AMR in Renal Transplant Recipients
    Lee, H.
    Shin, K.
    Kim, I.
    Choi, B.
    Kim, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S692 - S693
  • [28] DONOR SPECIFIC ANTI-HLA ANTIBODIES IN TRANSPLANT GLOMERULOPATHY
    Eng, Hooi Sian
    Bennett, Greg
    Tsiopelas, Eleni
    Chang, Sean
    Bardy, Peter
    Russ, Graeme
    Coates, P. Toby H.
    HUMAN IMMUNOLOGY, 2008, 69 : S109 - S109
  • [29] The Fate of Pre-Transplant Donor-Specific Anti-HLA Antibodies after Transplantation
    Marfo, K.
    Ling, M.
    Greenstein, S.
    Chapochnick-Friedmann, J.
    Glicklich, D.
    Kayler, L.
    de Boccardo, G.
    Kinkhabwala, M.
    Akalin, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 234 - 234
  • [30] RENAL TRANSPLANT FAILURE AND PRE-FORMED DONOR-SPECIFIC ANTI-HLA DP ANTIBODIES: A CASE REPORT
    Cardillo, Massimo
    Longhi, Elena
    Rampino, Teresa
    Gregorini, Marilena
    Abelli, Massimo
    Nocco, Angela
    Ramondetta, Miriam
    Innocente, Annalisa
    Sioli, Viviana
    Crespiatico, Loretta
    Puglisi, Giuseppe
    Piccolo, Giuseppe
    HLA, 2016, 87 (04) : 252 - 252
12345